PL2460806T3 - Związek zawierający azot z pierścieniem spiro i jego zastosowanie lecznicze - Google Patents

Związek zawierający azot z pierścieniem spiro i jego zastosowanie lecznicze

Info

Publication number: PL2460806T3
Authority: PL; Poland
Prior art keywords: nitrogen; same; ring compound; medicinal use; containing spiro
Prior art date: 2009-07-31

Application number

PL10804531T

Other languages

English (en)

Inventor

Satoru Noji

Makoto Shiozaki

Tomoya Miura

Yoshinori Hara

Hiroshi Yamanaka

Katsuya Maeda

Akimi Hori

Masafumi Inoue

Yasunori Hase

Original Assignee

Japan Tobacco, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-07-31

Filing date

2010-07-30

Publication date

2017-06-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43529436&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2460806(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-07-30 Application filed by Japan Tobacco, Inc. filed Critical Japan Tobacco, Inc.

2017-06-30 Publication of PL2460806T3 publication Critical patent/PL2460806T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Transplantation (AREA)
Biomedical Technology (AREA)
Otolaryngology (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL10804531T 2009-07-31 2010-07-30 Związek zawierający azot z pierścieniem spiro i jego zastosowanie lecznicze PL2460806T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2009179502		2009-07-31
US27413709P	2009-08-13	2009-08-13
EP10804531.1A EP2460806B1 (en)	2009-07-31	2010-07-30	Nitrogen-containing spiro-ring compound and medicinal use of same

Publications (1)

Publication Number	Publication Date
PL2460806T3 true PL2460806T3 (pl)	2017-06-30

Family

ID=43529436

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10804531T PL2460806T3 (pl)	2009-07-31	2010-07-30	Związek zawierający azot z pierścieniem spiro i jego zastosowanie lecznicze

Country Status (36)

Country	Link
US (4)	US8609647B2 (pl)
EP (3)	EP2460806B1 (pl)
JP (9)	JP5520158B2 (pl)
KR (1)	KR101773208B1 (pl)
CN (1)	CN102510865B (pl)
AR (1)	AR077497A1 (pl)
AU (1)	AU2010278066B2 (pl)
BR (1)	BR112012002157B1 (pl)
CA (1)	CA2767899C (pl)
CO (1)	CO6491052A2 (pl)
CY (1)	CY1118747T1 (pl)
DK (1)	DK2460806T3 (pl)
ES (1)	ES2616705T3 (pl)
FI (1)	FIC20250012I1 (pl)
FR (1)	FR25C1010I1 (pl)
HR (1)	HRP20170447T1 (pl)
HU (2)	HUE033070T2 (pl)
IL (1)	IL217048A (pl)
LT (2)	LT2460806T (pl)
ME (1)	ME02667B (pl)
MX (1)	MX2012001313A (pl)
MY (1)	MY163495A (pl)
NL (1)	NL301321I2 (pl)
NO (1)	NO2025014I1 (pl)
NZ (1)	NZ597994A (pl)
PE (1)	PE20121276A1 (pl)
PL (1)	PL2460806T3 (pl)
PT (1)	PT2460806T (pl)
RS (1)	RS55913B1 (pl)
RU (1)	RU2630694C2 (pl)
SG (1)	SG176918A1 (pl)
SI (1)	SI2460806T1 (pl)
SM (1)	SMT201700166T1 (pl)
TW (1)	TWI466885B (pl)
WO (1)	WO2011013785A1 (pl)
ZA (1)	ZA201200689B (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI466885B (zh) *	2009-07-31	2015-01-01	Japan Tobacco Inc	含氮螺環化合物及其醫藥用途
WO2011029043A1 (en)	2009-09-04	2011-03-10	Biogen Idec Ma Inc.	Heteroaryl btk inhibitors
MX2013001970A (es) *	2010-08-20	2013-08-09	Hutchison Medipharma Ltd	Compuestos de pirrolopirimidina y usos de los mismos.
EP2651417B1 (en)	2010-12-16	2016-11-30	Calchan Limited	Ask1 inhibiting pyrrolopyrimidine derivatives
CN103415520B8 (zh)	2011-12-21	2017-04-05	江苏恒瑞医药股份有限公司	吡咯并六元杂芳环类衍生物、其制备方法及其在医药上的应用
US20140343034A1 (en) *	2013-04-25	2014-11-20	Japan Tobacco Inc.	Skin barrier function improving agent
WO2015060208A1 (ja)	2013-10-21	2015-04-30	日本たばこ産業株式会社	眼疾患の治療剤又は予防剤
CA2948444C (en) *	2014-05-28	2022-07-26	Astrazeneca Ab	Processes for the preparation of azd5363 and intermediate used therein
HK1251223A1 (en) *	2015-07-07	2019-01-25	Japan Tobacco, Inc.	Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
WO2017013270A1 (en)	2015-07-23	2017-01-26	Universite De Strasbourg	Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy
SI3352734T1 (sl) *	2015-09-24	2020-07-31	Leo Pharma A/S	Zdravljenje alopecije areata
PT3353168T (pt) *	2015-09-25	2023-09-20	Dizal Jiangsu Pharmaceutical Co Ltd	Compostos e métodos para inibir jak
KR20180102662A (ko) *	2016-01-21	2018-09-17	레오 파마 에이/에스	손 습진의 치료
PE20190501A1 (es)	2016-08-01	2019-04-10	Aptinyx Inc	Moduladores nmda espiro-lactam y metodos de uso de los mismos
AU2017366400B2 (en)	2016-11-23	2021-08-26	Jiangsu Hengrui Medicine Co., Ltd.	Preparation method for and intermediate of pyrrolo six-membered heteroaromatic ring derivative
CN110300756B (zh) *	2016-12-21	2024-01-02	日本烟草产业株式会社	7H-吡咯并[2,3-d]嘧啶衍生物的制备方法及其合成中间体
JP2020502224A (ja) *	2016-12-21	2020-01-23	日本たばこ産業株式会社	ヤヌスキナーゼ阻害剤の結晶形
BR112019012267A2 (pt) *	2016-12-21	2019-12-03	Japan Tobacco Inc	processo para a preparação do derivado de 7h-pirrolo [2,3-d]pirimidina e cocristais do mesmo
WO2018134352A1 (en)	2017-01-20	2018-07-26	Leo Pharma A/S	Bicyclic amines as novel jak kinase inhibitors
CN110248663A (zh) *	2017-02-03	2019-09-17	利奥制药有限公司	作为新型JAK激酶抑制剂的5-(7H-吡咯并[2,3-d]嘧啶-4-基)-5-氮杂螺[2.5]辛烷-8-甲酸衍生物
MA50371A (fr) *	2017-10-10	2021-03-31	Biogen Inc	Procédé de préparation de dérivés spiro
JP2021512109A (ja) *	2018-01-31	2021-05-13	アプティニックスインコーポレイテッド	スピロラクタム系ｎｍｄａ受容体修飾因子およびその使用
CN112384514A (zh) *	2018-07-06	2021-02-19	利奥制药有限公司	作为janus激酶抑制剂的新的氨基-咪唑并嘧啶衍生物及其药物用途
WO2020092015A1 (en)	2018-11-02	2020-05-07	University Of Rochester	Therapeutic mitigation of epithelial infection
WO2020229622A1 (en)	2019-05-15	2020-11-19	Leo Pharma A/S	Treatment of cutaneous lupus erythematosus
CN114173788A (zh) *	2019-08-07	2022-03-11	乐敦制药株式会社	泪液分泌促进用眼科组合物
WO2021132598A1 (ja) *	2019-12-27	2021-07-01	ロート製薬株式会社	水性組成物
CN111574540B (zh) *	2020-06-30	2023-08-29	云南华派医药科技有限公司	一种德高替尼的制备方法
CN111606929B (zh) *	2020-06-30	2023-07-07	中瀚(齐河县)生物医药科技有限公司	德高替尼的制备方法
CN111560021B (zh) *	2020-06-30	2023-05-26	上海鲲博玖瑞医药科技发展有限公司	一种德高替尼中间体及其制备方法
CN114591321A (zh) *	2020-12-04	2022-06-07	广州费米子科技有限责任公司	氮杂并环化合物、其制备方法及其用途
CN116635026A (zh) *	2020-12-29	2023-08-22	上海岸阔医药科技有限公司	治疗与抗肿瘤剂相关的皮肤疾病或病症的试剂和方法
WO2023202989A1 (en)	2022-04-20	2023-10-26	Leo Pharma A/S	Treatment of frontal fibrosing alopecia
AU2024229918A1 (en)	2023-02-28	2025-09-18	Assia Chemical Industries Ltd.	Solid state forms of delgocitinib and process thereof
KR20250159260A (ko)	2023-03-17	2025-11-10	레오 파마 에이/에스	중등도 내지 중증의 만성 손 습진 환자의 만성 손 습진 치료 방법
WO2024225445A1 (en)	2023-04-27	2024-10-31	Japan Tobacco Inc.	Crystalline form of delgocitinib
WO2025085050A1 (en) *	2023-10-16	2025-04-24	Leo Pharma A/S	Treatment of frontal fibrosing alopecia

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU76100A (sh)	1998-06-02	2003-12-31	Osi Pharmaceuticals Inc.	Pirolo(2,3-d) pirimidin preparati i njihova primena
PA8474101A1 (es) *	1998-06-19	2000-09-29	Pfizer Prod Inc	Compuestos de pirrolo [2,3-d] pirimidina
WO1999065908A1 (en) *	1998-06-19	1999-12-23	Pfizer Products Inc.	PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
GEP20053479B (en)	1999-12-10	2005-03-25	Pfizer Prod Inc	Pyrrolo[2,3-d]Pyrimidine Compounds, Pharmaceutical Composition Containing the Same and Use
DE60330456D1 (de) *	2002-07-05	2010-01-21	Targacept Inc	N-aryl diazaspirozyklische verbindungen, deren verwendung und das verfahren zu ihren herstellung
EP1683797A1 (en)	2003-11-13	2006-07-26	Ono Pharmaceutical Co., Ltd.	Heterocyclic spiro compound
AR054416A1 (es) *	2004-12-22	2007-06-27	Incyte Corp	Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
EP1858902A1 (en)	2005-02-24	2007-11-28	Pfizer Products Incorporated	Bicyclic heteroaromatic derivatives useful as anticancer agents
US8921376B2 (en) *	2005-05-20	2014-12-30	Vertex Pharmaceuticals Incorporated	Pyrrolopyridines useful as inhibitors of protein kinase
US8163767B2 (en)	2005-07-14	2012-04-24	Astellas Pharma Inc.	Heterocyclic Janus Kinase 3 inhibitors
ATE525374T1 (de)	2005-12-13	2011-10-15	Incyte Corp	Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
GB0526246D0 (en) *	2005-12-22	2006-02-01	Novartis Ag	Organic compounds
WO2007084667A2 (en)	2006-01-19	2007-07-26	Osi Pharmaceutical, Inc.	Fused heterobicyclic kinase inhibitors
WO2007103719A2 (en)	2006-03-03	2007-09-13	Incyte Corporation	MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2008029237A2 (en)	2006-09-05	2008-03-13	Pfizer Products Inc.	Combination therapies for rheumatoid arthritis
US7678806B2 (en)	2006-12-22	2010-03-16	Hoffmann-La Roche Inc.	Spiro-piperidine derivatives
TW200904437A (en) *	2007-02-14	2009-02-01	Janssen Pharmaceutica Nv	2-aminopyrimidine modulators of the histamine H4 receptor
PE20090996A1 (es) *	2007-04-02	2009-07-15	Palau Pharma Sa	Derivados de pirrolopirimidina como inhibidores de cinasa jak3
WO2009047255A1 (en) *	2007-10-09	2009-04-16	Ucb Pharma, S.A.	Heterobicyclic compounds as histamine h4-receptor antagonists
JP5512545B2 (ja)	2008-01-09	2014-06-04	アレイバイオファーマ、インコーポレイテッド	Ａｋｔタンパク質キナーゼ阻害剤としてのピリミジルシクロペンタン類
AR071717A1 (es)	2008-05-13	2010-07-07	Array Biopharma Inc	Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
EP2320895A2 (en)	2008-07-03	2011-05-18	Exelixis, Inc.	Cdk modulators
WO2010135650A1 (en)	2009-05-22	2010-11-25	Incyte Corporation	N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
TWI466885B (zh) *	2009-07-31	2015-01-01	Japan Tobacco Inc	含氮螺環化合物及其醫藥用途
GB0913342D0 (en)	2009-07-31	2009-09-16	Astrazeneca Ab	Compounds - 801
WO2011029043A1 (en)	2009-09-04	2011-03-10	Biogen Idec Ma Inc.	Heteroaryl btk inhibitors
JP2018028525A (ja) *	2016-08-15	2018-02-22	小野　信行	イオンレーザーと重水素を利用した核融合炉
JP6229778B2 (ja) *	2016-09-21	2017-11-15	サミー株式会社	遊技機

2010
- 2010-07-22 TW TW99124110A patent/TWI466885B/zh active
- 2010-07-23 AR ARP100102681A patent/AR077497A1/es active IP Right Grant
- 2010-07-30 RU RU2012106344A patent/RU2630694C2/ru active
- 2010-07-30 AU AU2010278066A patent/AU2010278066B2/en active Active
- 2010-07-30 CN CN201080034068.1A patent/CN102510865B/zh active Active
- 2010-07-30 KR KR1020127001455A patent/KR101773208B1/ko active Active
- 2010-07-30 ES ES10804531.1T patent/ES2616705T3/es active Active
- 2010-07-30 LT LTEP10804531.1T patent/LT2460806T/lt unknown
- 2010-07-30 EP EP10804531.1A patent/EP2460806B1/en active Active
- 2010-07-30 HU HUE10804531A patent/HUE033070T2/hu unknown
- 2010-07-30 US US12/847,025 patent/US8609647B2/en active Active
- 2010-07-30 SG SG2011094117A patent/SG176918A1/en unknown
- 2010-07-30 SM SM20170166T patent/SMT201700166T1/it unknown
- 2010-07-30 ME MEP-2017-74A patent/ME02667B/me unknown
- 2010-07-30 PL PL10804531T patent/PL2460806T3/pl unknown
- 2010-07-30 RS RS20170305A patent/RS55913B1/sr unknown
- 2010-07-30 BR BR112012002157-5A patent/BR112012002157B1/pt active IP Right Grant
- 2010-07-30 EP EP21159390.0A patent/EP3858349A1/en active Pending
- 2010-07-30 PT PT108045311T patent/PT2460806T/pt unknown
- 2010-07-30 HR HRP20170447TT patent/HRP20170447T1/hr unknown
- 2010-07-30 SI SI201031426A patent/SI2460806T1/sl unknown
- 2010-07-30 EP EP17150170.3A patent/EP3181570A1/en not_active Withdrawn
- 2010-07-30 MX MX2012001313A patent/MX2012001313A/es active IP Right Grant
- 2010-07-30 CA CA2767899A patent/CA2767899C/en active Active
- 2010-07-30 JP JP2010171260A patent/JP5520158B2/ja active Active
- 2010-07-30 WO PCT/JP2010/062873 patent/WO2011013785A1/ja not_active Ceased
- 2010-07-30 PE PE2012000097A patent/PE20121276A1/es active IP Right Grant
- 2010-07-30 NZ NZ597994A patent/NZ597994A/xx unknown
- 2010-07-30 MY MYPI2012000155A patent/MY163495A/en unknown
- 2010-07-30 DK DK10804531.1T patent/DK2460806T3/en active
2011
- 2011-12-18 IL IL217048A patent/IL217048A/en active IP Right Grant
2012
- 2012-01-18 CO CO12006869A patent/CO6491052A2/es active IP Right Grant
- 2012-01-27 ZA ZA2012/00689A patent/ZA201200689B/en unknown
2013
- 2013-11-12 US US14/077,446 patent/US20140187534A1/en not_active Abandoned
2014
- 2014-04-04 JP JP2014077850A patent/JP2014141516A/ja active Pending
2015
- 2015-11-17 JP JP2015224910A patent/JP2016029104A/ja not_active Ceased
2016
- 2016-11-02 JP JP2016214954A patent/JP2017019877A/ja not_active Ceased
2017
- 2017-03-20 CY CY20171100348T patent/CY1118747T1/el unknown
2018
- 2018-02-21 JP JP2018028525A patent/JP2018111701A/ja not_active Ceased
2019
- 2019-12-04 JP JP2019219283A patent/JP2020033384A/ja not_active Withdrawn
2021
- 2021-09-06 JP JP2021144545A patent/JP2021183653A/ja not_active Withdrawn
- 2021-12-21 US US17/557,174 patent/US20230023377A1/en not_active Abandoned
2023
- 2023-05-05 US US18/143,720 patent/US20240150367A1/en not_active Abandoned
- 2023-08-07 JP JP2023128376A patent/JP2023138641A/ja not_active Withdrawn
2025
- 2025-02-28 FI FIC20250012C patent/FIC20250012I1/fi unknown
- 2025-02-28 FR FR25C1010C patent/FR25C1010I1/fr active Active
- 2025-03-03 HU HUS2500013C patent/HUS2500013I1/hu unknown
- 2025-03-03 LT LTPA2025511C patent/LTPA2025511I1/lt unknown
- 2025-03-04 NO NO2025014C patent/NO2025014I1/no unknown
- 2025-03-04 NL NL301321C patent/NL301321I2/nl unknown
- 2025-05-08 JP JP2025077764A patent/JP2025109780A/ja active Pending

Also Published As

Publication number	Publication date
AU2010278066A1 (en)	2012-03-01
PT2460806T (pt)	2017-02-27
WO2011013785A1 (ja)	2011-02-03
CA2767899C (en)	2018-08-28
US20230023377A1 (en)	2023-01-26
PE20121276A1 (es)	2012-09-27
FIC20250012I1 (fi)	2025-02-28
NL301321I2 (nl)	2025-07-17
TWI466885B (zh)	2015-01-01
JP2021183653A (ja)	2021-12-02
JP2018111701A (ja)	2018-07-19
JP2023138641A (ja)	2023-10-02
EP2460806B1 (en)	2017-01-04
ZA201200689B (en)	2012-10-31
JP2017019877A (ja)	2017-01-26
MY163495A (en)	2017-09-15
EP3181570A1 (en)	2017-06-21
US20140187534A1 (en)	2014-07-03
RU2012106344A (ru)	2013-08-27
AU2010278066B2 (en)	2016-04-14
IL217048A (en)	2014-12-31
MX2012001313A (es)	2012-02-29
KR101773208B1 (ko)	2017-08-31
BR112012002157A2 (pt)	2020-08-18
DK2460806T3 (en)	2017-03-20
EP2460806A1 (en)	2012-06-06
CA2767899A1 (en)	2011-02-03
ME02667B (me)	2017-06-20
NO2025014I1 (no)	2025-03-04
JP2020033384A (ja)	2020-03-05
EP2460806A4 (en)	2012-12-26
TW201107325A (en)	2011-03-01
SI2460806T1 (sl)	2017-04-26
ES2616705T3 (es)	2017-06-14
HUS2500013I1 (hu)	2025-03-28
NZ597994A (en)	2013-08-30
JP2011046700A (ja)	2011-03-10
IL217048A0 (en)	2012-02-29
AR077497A1 (es)	2011-08-31
SG176918A1 (en)	2012-01-30
US20240150367A1 (en)	2024-05-09
BR112012002157B1 (pt)	2022-02-08
LTPA2025511I1 (pl)	2025-03-25
CN102510865B (zh)	2015-04-15
JP2016029104A (ja)	2016-03-03
EP3858349A1 (en)	2021-08-04
CY1118747T1 (el)	2017-07-12
HRP20170447T1 (hr)	2017-05-19
FR25C1010I1 (fr)	2025-04-25
SMT201700166T1 (it)	2017-05-08
JP2025109780A (ja)	2025-07-25
LT2460806T (lt)	2017-02-10
CO6491052A2 (es)	2012-07-31
RS55913B1 (sr)	2017-09-29
JP5520158B2 (ja)	2014-06-11
US8609647B2 (en)	2013-12-17
RU2630694C2 (ru)	2017-09-12
HUE033070T2 (hu)	2017-11-28
CN102510865A (zh)	2012-06-20
KR20120051649A (ko)	2012-05-22
US20110136778A1 (en)	2011-06-09
JP2014141516A (ja)	2014-08-07

Publication	Publication Date	Title
HUS2500013I1 (hu)	2025-03-28	Nitrogén-tartalmú spiro-gyûrûs vegyület és ennek gyógyászati alkalmazása
ZA201301120B (en)	2014-04-30	Heterocyclic compound and use thereof
EP2464227A4 (en)	2013-02-20	COMPOUNDS AND METHODS OF USE
IL222227A0 (en)	2012-12-31	Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
EP2539005A4 (en)	2015-12-23	ORAL PIECE AND METHODS OF USING THE SAME
IL213547A0 (en)	2011-07-31	Compounds and methods of use
EP2340244A4 (en)	2012-07-25	COMPOUNDS AND APPLICATION PROCEDURES
SG10201405568UA (en)	2014-11-27	4-substituted pyridin-3-yl-carboxamide compounds and methods of use
ZA201200797B (en)	2012-10-31	Bicyclic compound and use thereof for medical purposes
IL236830A0 (en)	2015-03-31	Diazahomoredene derivatives and methods of using them
ZA201201287B (en)	2013-05-29	Therapeutic aryl-amido-aryl compounds and their use
ZA201303773B (en)	2014-11-26	Compounds and their use
ZA201304012B (en)	2014-02-26	Novel compound and medical use thereof
GB0902173D0 (en)	2009-03-25	Compounds and their use
GB0922510D0 (en)	2010-02-10	Compound and use
EP2381950A4 (en)	2012-08-22	COMPOSITIONS AND METHOD FOR THEIR USE
ZA200903082B (en)	2011-04-28	Eslicarbazepine acetate and methods of use
HU0900647D0 (en)	2009-11-30	Salts of 7-nitroindoline derivatives and use thereof
GB0913300D0 (en)	2009-09-02	Therapeutic compounds and their use
GB201020848D0 (en)	2011-01-26	Compounds and their use
GB201018028D0 (en)	2010-12-08	Compounds and their use
GB201000307D0 (en)	2010-02-24	Compounds and their use
GB201017822D0 (en)	2010-12-01	Compounds and their use
GB201005511D0 (en)	2010-05-19	Compounds and their use
GB201000305D0 (en)	2010-02-24	Compounds and their use